FDA commissioner says decision on psychedelic treatments will be out 'quickly'
05:56
UP NEXT
Amazon Launches GLP-1 Program: Does It Save You Money?
01:43
RFK Jr. Defends Vaccine Policies, Handling of Measles Outbreak
02:15
What are peptides and why is the FDA considering easing limits?
03:09
Nursing profession sees major boom
01:46
Trump signs order to speed up review of psychedelic drugs for mental health treatment
03:14
Dietitian Shares Tips on How to Read (and Decode) Food Labels
04:35
How GLP-1s, Male Factors, and Lifestyle Affect Fertility Issues
04:43
Ryan Reynolds and Willie Geist Talk Dads With Parkinson’s Disease
04:17
Trump signs order to accelerate access to psychedelic drug treatments
01:25
Indiana parents fight to reunite with children after suspicion of abuse
07:07
Can You Keep Expired Medications?
04:40
Son speaks about mother’s death after operation by surgeon arrested in separate case
01:47
Kennedy faces questioning on measles and preventative services at House hearing
02:19
How to Know If Insurance Will Cover Your GLP-1 Medications
05:12
Should insurance cover weight loss drugs?
03:23
Dr. Pimple Popper Shares Her Product Picks for Glowy Skin
02:43
Sandra Lee, TV's Dr. Pimple Popper, Opens Up About Her Stroke
04:34
Lena Dunham on New Memoir, Adam Driver, Jack Antonoff, More
14:59
How to Improve Sleep Quality and Build Habits to Get More Rest
06:31
NBC News NOW
FDA commissioner says decision on psychedelic treatments will be out 'quickly'
Catch up with NBC News Clone on today's hot topic: Fda Commissioner Says Decision On Psychedelic Treatments Will Be Out Quickly 261912133760 - Breaking News | NBC News Clone. Our editorial team reformatted this story for clarity and speed.
05:56
Copied
FDA Commissioner Dr. Marty Makary tells NBC News that the government "owes" veterans a speedy decision on psychedelic drugs that could help people struggling with drug addiction and suicidal ideation. President Donald Trump ignited wide interest in the psychedelic ibogaine when he signed an executive order meant to spur research into it and other substances touted as beneficial for patients struggling with ailments, such as PTSD.April 22, 2026
